Shares of Houlihan Lokey (HLI) soared 5.10% in Thursday's trading session, following a series of positive analyst actions. The investment banking firm saw its stock price climb as multiple financial institutions revised their outlook on the company.
Morgan Stanley led the charge by raising its price target on Houlihan Lokey to $159.00 from $156.00, signaling increased confidence in the company's future performance. This move was followed by Wells Fargo, which not only maintained its Overweight rating on HLI but also significantly boosted its price target to $185 from $170, representing one of the more bullish stances on Wall Street.
While JP Morgan slightly trimmed its price target to $167 from $169, the overall sentiment remained positive. The flurry of analyst activity suggests a growing optimism about Houlihan Lokey's business prospects, particularly in the current market environment where financial advisory services are in high demand. Investors appear to be responding favorably to these expert assessments, driving the stock's impressive intraday gain.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.